{"nct_id":"NCT01602315","title":"A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma","status":"TERMINATED","status_verified_date":"2018-04","start_date":"2012-11-12","start_date_type":"ACTUAL","primary_completion_date":"2016-09-16","primary_completion_date_type":"ACTUAL","completion_date":"2016-09-16","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["NVS"]}